miami glp-1 lawsuit class action in Ozempic Lawsuit: May 2026 Blindness and Gastroparesis Claims Miami Zepbound Lawsuit Lawyer |

The market, valued at USD 3.1 billion in 2026, is projected to reach USD 15.4 billion by 2036, registering a CAGR of 17.4% during the forecast period

MIN6 and Figure 4

These data suggest the potential of semaglutide and similar drugs to fill an unmet need for the treatment of alcohol use disorder, said senior author Klara Klein of the University of North Carolina School of Medicine

Since branded semaglutide and tirzepatide are now fully available, prescribers are expected to document that the compounded version serves a specific individualized medical need that the branded version cannot

Why Weight Gain During Menopause is So Common To understand how semaglutide-containing medications like Ozempic and Wegovy can lead to such dramatic weight loss it helps to have a grasp on why menopausal weight gain happens in the first place

Unregulated compounded GLP-1 products carry serious safety concerns because they are not reviewed or approved by the FDA for safety, effectiveness, or quality